ARTICLE | Company News
Benitec, Stanford University deal
October 25, 2004 7:00 AM UTC
BLT received an exclusive license from the university to use Minicircle DNA technology for all RNAi therapeutic uses. BLT also has sublicensing rights. The company said the technology allows for non-v...